Can Patients With Atrial Fibrillation Read Their Own Rhythm Recording Using a Novel Wireless ECG Recording System? iRead Study
This trial is active, not recruiting.
|Conditions||atrial fibrillation, atrial flutter|
|Sponsor||The Cleveland Clinic|
|Start date||August 2014|
|End date||August 2014|
|Trial size||60 participants|
|Trial identifier||NCT02214069, 14-612|
The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and whether they can interpret the recordings on their own. AliveCor is a new monitoring technology used with a smart phone which allows patients to record their rhythm. The investigators goal is to assess if patients can use the AliveCor to record their rhythm, interpret the rhythm results to assess whether they are in sinus rhythm (normal rhythm) or atrial fibrillation/flutter.
Examine whether patients can use the AliveCor case to record their rhythm and whether they can interpret the recordings on their own.
time frame: 6 month
Assess the correlation between QT interval derived from the AliveCor device compared to standard 12 lead ECG, as assessed by the overreading electrophysiologists.
time frame: 6 montha
Male or female participants from 18 years up to 80 years old.
Inclusion Criteria: 1. Male or female between > 18 and < 80 years of age 2. Paroxysmal or persistent atrial fibrillation 3. Admitted for antiarrhythmic drug loading (Dofetilide or Sotalol) 4. Already has iPhone 4, 4S or 5 with data plan that accommodates the AliveCor case 5. Willing to use the Alive Cor case 6. Written informed consent Exclusion Criteria: 1. Unable or unwilling to use the Alive Cor case for their smart phone 2. Presence of a permanent pacemaker
Call for more information